Valuation: UCB

Market Cap 42.54B 49.18B 39.72B 36.44B 68.54B 4,680B 69.63B 466B 183B 2,346B 185B 181B 7,755B P/E 2026 *
22.7x
P/E 2027 * 18.4x
Enterprise Value 42.71B 49.38B 39.89B 36.59B 68.82B 4,699B 69.91B 468B 184B 2,355B 185B 181B 7,787B EV / Sales 2026 *
4.94x
EV / Sales 2027 * 4.19x
Free-Float
61.59%
Yield 2026 *
0.65%
Yield 2027 * 0.67%
1 day-0.84%
1 week+0.09%
Current month+0.09%
1 month-12.10%
3 months-4.17%
6 months-14.85%
Current year-6.50%
1 week 219.8
Extreme 219.8
232.9
1 month 214
Extreme 214
254.3
Current year 214
Extreme 214
289.5
1 year 184.75
Extreme 184.75
289.5
3 years 65.4
Extreme 65.4
289.5
5 years 65.4
Extreme 65.4
289.5
10 years 54.84
Extreme 54.84
289.5
Manager TitleAgeSince
Chief Executive Officer 67 2014-12-31
Director of Finance/CFO 60 2020-06-30
Chief Tech/Sci/R&D Officer 59 2024-04-30
Director TitleAgeSince
Director/Board Member 55 2011-12-31
Director/Board Member 67 2014-12-31
Director/Board Member 56 2014-04-23
Date Insider Type Main position Quantity % Market Cap.
1/15/26 Fiscal year

Executive/Senior Manager

3,000 0.0015%
1/15/26 Fiscal year

Executive/Senior Manager

3,000 0.0015%
1/15/26 Buy

Director

500 0.0003%
Change 5-day change 1-year change 3-year change Capi.($)
-0.84%+0.09%+20.92%+179.15% 49.18B
+1.59%+2.85%+40.11%+1.24% 78.32B
+2.77%+4.78%-1.65%+27.62% 51.1B
-0.13%+7.42%-50.22%-49.58% 44.71B
+0.80%+2.46%+62.77%-23.33% 30.72B
+1.84%+0.87%+54.17%+85.73% 24.44B
+9.86%+7.94%+122.36%-41.53% 23.62B
+4.29%+9.40%+3.77%+226.51% 21.05B
+1.66%-3.70%+65.40%+123.91% 16.61B
+2.03%+5.48%+83.85%+172.87% 16.51B
Average +2.39%+4.22%+40.15%+70.26% 35.63B
Weighted average by Cap. +1.89%+4.35%+29.57%+51.03%

Financials

2026 *2027 *
Net sales 8.65B 10B 8.08B 7.41B 13.94B 952B 14.16B 94.78B 37.2B 477B 37.55B 36.73B 1,577B 9.7B 11.21B 9.06B 8.31B 15.63B 1,067B 15.88B 106B 41.71B 535B 42.11B 41.19B 1,768B
Net income 1.87B 2.16B 1.75B 1.6B 3.02B 206B 3.07B 20.52B 8.05B 103B 8.13B 7.95B 341B 2.34B 2.71B 2.19B 2.01B 3.77B 258B 3.83B 25.66B 10.07B 129B 10.17B 9.94B 427B
Net Debt 174M 202M 163M 149M 281M 19.2B 286M 1.91B 750M 9.62B 757M 741M 31.81B -1.94B -2.24B -1.81B -1.66B -3.13B -213B -3.18B -21.26B -8.34B -107B -8.42B -8.24B -354B
Logo UCB
UCB is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system.
Employees
9,000
Date Price Change Volume
26-08-07 €223.10 -0.84% 194,018
26-08-06 €225.00 -1.83% 193,762
26-08-05 €229.20 +2.64% 264,506
26-08-04 €223.30 +0.86% 258,008
26-08-03 €221.40 -0.67% 305,551
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
20
Last Close Price
223.10EUR
Average target price
286.11EUR
Spread / Average Target
+28.24%

Quarterly revenue - Rate of surprise